Drug Mechanisms Flashcards
Mechanism of action of typical antipsychotics
(a) pathway of therapeutic efficacy
Antagonism of dopamine D2 receptors
(a) Therapeutic efficacy against positive symptoms due to D2 blockade in mesolimbic dopamine pathway
What side effects does D2 blockade cause by blocking the following pathways
(a) nigrostriatal
(b) tuberoinfundibular
(c) mesocortical
Dopmaine pathways
(a) Nigrostriatal blockade => EPS
(b) Tuberoinfundibular blockade => hyperprolactinemia
(c) Mesocortical blockade worsens negative symptoms (alogia, avolition) and cognitive symptoms (poor attention and vigilance)
3 receptors (besides DA) antagonized by typical antipsychotics
Anti:
- histamine-1
- alpha-adrenergic
- muscarinic (type of cholinergic)
General mechanism of atypical antipsychotics
Antagonism of D2 and 5HT2 receptors
dopamine D2 and serotonin 2A receptors
Describe the effect of the 2 receptors blocked by atypical antipsychotics
(i) Blocking D2 in the mesolimbic dopamine pathway = therapeutic effect against positive symptoms (ex: hallucinations, delusions)
(i) Blocking 5HT2A in mesocortical, nigrostriatal, and tuberoinfundibular pathways enhances DA transmission => mitigating ‘typical’ side effects
What receptors do atypical antipsychotics block?
- Therapeutically: D2 blockade
- Decreased ‘typical’ side effects due to 5HT2A blockade
Also blocks to varying degrees:
muscarinic, alpha-adrenergic, histamine-1
Mechanism of clozapine
Atypical antipsychotic
-wide antagonism: 5HT2A, D1, D2, D4, H1, muscarinic, and alpha1
Mechanism of risperidone
Atypical antipsychotic
-antagonism: 5HT2A, D2, alpha1
Mechanism of olanzapine
Atypical antipsychotic
- wide antagonism: 5HT2A, D1, D2, D4, H1, muscarinic, and alpha 1 (same as clozapine)
- among the atypicals, may have efficacy second only to clozapine
Mechanism of quetipaine
Atypical antipsychotic (quetiapine = Seroquel) -antagonism: 5HT2A, D2, alpha1, alpha2, H1
Mechanism of ziprasidone
Atypical antipsychotic
(ziprasidone = Geodon)
-antagonism: 5HT1A, 5HT2A, D2, D3, and monoamine reuptake pumps (NE, 5HT, DA)
Which antipsychotic inhibits monoamine reuptake pumps?
Ziprasidone (= Geodon)
Which atypical antipsychotics antagonize muscarinic receptors?
- clozapine
- olanzapine
Mechanism of aripiprazole
Aripiprazole (Abilify) = atypical antipsychotic
- antagonism: 5HT2A
- partial agonism: D2, 5HT1A
Mechanism of therapeutic action for TCAs
Tricyclic Antidepressants proposed mechanism:
antagonism at serotonin (5HT) and NE presynaptic reuptake pumps
-Not fully understood- may involve receptor and downstream secondary messenger transcription changes
Name all the receptors blocked by TCAs
Therapeutically block reuptake pumps: 5HT and NE
Block receptors: muscarinic, alpha-adrenergic, H1
Latency period of TCA activity
3-4 weeks of administration for therapeutic effect to begin
What is the difference btwn the two groups of TCAs?
TCAs grouped into tertiary and secondary amines b/c this predicts side effect profile
Tertiary amines: greater alpha, H1, and muscarinic blockade
Newer, secondary amines: fewer side effects, less sedating, safer in OD
Mechanism of action of MAOIs
Irreversible MAO (monoamine oxidase) inhibitors -MAO metabolizes monoamines (5HT, DA, and NE) in the presynaptic neuron => MAO inhibition disables momamine degradation
MAO-A vs. MAO-B
(a) Which is blocked by psychiatric drugs?
(b) Which blockade is necessary for therapeutic effect?
MAO-A vs. MAO-B
(a) Psychiatric drugs block both
(b) Only MAO-A blockade is necessary for the anti-depressant effect. MAO-A is used to break down tyramine